Medibuddy reports FY25 revenue of Rs 725 Cr, reducing losses by 37%.

MediBuddy, a digital healthcare platform, reported a little increase in its operational scale in FY25 after growing by more than two times in the fiscal year that ended in March 2024. Nonetheless, the business was able to reduce its losses by 37% over that time. According to MediBuddy's annual financial records submitted to the Registrar of Companies (RoC), the company's operating revenue increased 12.3% year over year to Rs 724.6 crore in FY25 from Rs 645.4 crore in FY24.MediBuddy is a digital healthcare business that offers insurance services, lab testing, procedures, online and offline medical consultations, and medication delivery. Together, these services' revenue of Rs 722 crore continued to be the company's main source of income, with additional operating sources contributing Rs 2.5 crore. The company's total income in FY25 was Rs 743 crore after earning Rs 18.42 crore from non-operating sources, such as interest on current assets and fixed deposits, written-off liabilities, and other miscellaneous income.The cost of materials, which was Rs 333 crore in the previous fiscal year, accounted for the highest portion of total expenses at 38%.

Employee benefits costs came next, rising slightly by 8% to Rs 176.8 crore, which included Rs 6 crore in ESOP costs. During the year, sales payout expenses, which include commissions paid to selling agents, decreased by 7% to Rs 155.47 crore. Additionally, the corporation spent Rs 32.5 crore on information technology and Rs 42.5 crore on safety and security. In FY25, additional overheads totalling Rs 138.7 crore included advertising, legal and professional fees, depreciation and amortisation, and financing charges.In the previous fiscal year, the Bengaluru-based company's total expenses stayed constant at Rs 879 crore. The company's losses were reduced by 37% to Rs 137 crore from Rs 215.7 crore in FY24 thanks to controlled spending and a 12% increase in sales.